EarningsQ1 2026 Earnings Report

Nektar Therapeutics (ITH0) Q1 2026 Earnings Report

1 Followers

DE:ITH0 Q1 2026 EPS Results

Actual EPS-€1.62

Consensus EPS-€1.41

Beat/MissMissed by -€0.21

One Year Ago EPS-€3.21

Actual Revenue€9.69M

Expected Revenue€9.54M

Beat/MissBeat by +€151.68K

YoY Revenue Growth+3.83%

QuarterQ1 2026

Date05/07/2026

TimeAfter Close

Conference CallThursday, May 7, 2026

DE:ITH0 Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:ITH0 Q1 2026 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.87 / -	-1.668	―
Aug 13, 2026	2026 (Q2)	-1.76 / -1.10	-2.632	58.31% (+1.53)
May 07, 2026	2026 (Q1)	-1.41 / -1.62	-3.212	49.44% (+1.59)
Mar 12, 2026	2025 (Q4)	-2.21 / -1.59	0.401	-495.56% (-1.99)
Nov 06, 2025	2025 (Q3)	-2.40 / -1.67	-2.409	30.74% (+0.74)
Aug 07, 2025	2025 (Q2)	-2.70 / -2.63	-3.346	21.33% (+0.71)
May 08, 2025	2025 (Q1)	-2.29 / -3.21	-2.543	-26.32% (-0.67)
Mar 12, 2025	2024 (Q4)	-1.81 / 0.40	-2.944	113.64% (+3.35)
Nov 07, 2024	2024 (Q3)	-2.66 / -2.41	-3.212	25.00% (+0.80)
Aug 08, 2024	2024 (Q2)	-2.48 / -3.35	-3.613	7.41% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed